Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 03940C100 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Paradigm Biocapital Advisors LP
13G/A
Amendment 4
|
0% |
8/14/2026
Event 6/30/2026
|
|
| Paradigm BioCapital Advisors LP | 0% | ||
| Paradigm BioCapital Advisors GP LLC | 0% | ||
| Senai Asefaw, M.D. | 0% | ||
| Paradigm BioCapital International Fund Ltd. | 0% | ||
|
Vestal Point Capital, LP
13G/A
Amendment 1
|
0% |
5/15/2026
Event 3/31/2026
|
|
| Vestal Point Capital, LP | 0% | ||
| Ryan Wilder | 0% | ||
|
New Enterprise Associates 15, L.P.
13D/A
Amendment 6
|
0% |
4/30/2026
Event 4/28/2026
|
|
| New Enterprise Associates 15, L.P. | 0% | ||
| NEA Partners 15, L.P. | 0% | ||
| Nea 15 GP, LLC | 0% | ||
| Forest Baskett | 0% | ||
| Anthony A. Florence, Jr. | 0% | ||
| Mohamad H. Makhzoumi | 0% | ||
| Scott D. Sandell | 0% | ||
| Rami Elghandour 13D/A Amendment 3 | 0% |
4/28/2026
Event 4/28/2026
|
|
| Gilead Sciences, Inc. 13D/A Amendment 1 | 100.0% |
4/28/2026
Event 4/28/2026
|
|
| Vanguard Group Inc 13G/A Amendment 2 | 0% |
3/26/2026
Event 3/13/2026
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 3 | 4.5% |
3/6/2026
Event 2/28/2026
|
|
|
FMR LLC
13G/A
Amendment 7
|
0.5% |
3/6/2026
Event 2/27/2026
|
|
| FMR LLC | 0.5% | ||
| Abigail P. Johnson | 0.5% | ||
| Rami Elghandour 13D/A Amendment 2 | 6.4% |
2/24/2026
Event 2/22/2026
|
|
|
New Enterprise Associates 15, L.P.
13D/A
Amendment 5
|
5.3% |
2/24/2026
Event 2/22/2026
|
|
| New Enterprise Associates 15, L.P. | 5.3% | ||
| NEA Partners 15, L.P. | 5.3% | ||
| Nea 15 GP, LLC | 5.3% | ||
| Forest Baskett | 5.3% | ||
| Anthony A. Florence, Jr. | 5.3% | ||
| Mohamad H. Makhzoumi | 5.3% | ||
| Scott D. Sandell | 5.3% | ||
| Gilead Sciences, Inc. 13D | 11.5% |
2/23/2026
Event 2/23/2026
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 | 18.3% |
2/17/2026
Event 12/31/2025
|
|
|
RA Capital Management, L.P.
13G/A
Amendment 1
|
2.2% |
2/17/2026
Event 12/31/2025
|
|
| RA Capital Management, L.P. | 2.2% | ||
| Peter Kolchinsky | 2.2% | ||
| Rajeev Shah | 2.2% | ||
| RA Capital Healthcare Fund, L.P. | 2.2% | ||
|
Paradigm Biocapital Advisors LP
13G/A
Amendment 3
|
9.9% |
2/17/2026
Event 12/31/2025
|
|
| Paradigm BioCapital Advisors LP | 9.9% | ||
| Paradigm BioCapital Advisors GP LLC | 9.9% | ||
| Senai Asefaw, M.D. | 9.9% | ||
| Paradigm BioCapital International Fund Ltd. | 8.7% | ||
|
Vestal Point Capital, LP
13G
|
5.1% |
2/17/2026
Event 12/31/2025
|
|
| Vestal Point Capital, LP | 5.1% | ||
| Ryan Wilder | 5.1% | ||
|
FMR LLC
13G/A
Amendment 6
|
6.2% |
2/5/2026
Event 12/31/2025
|
|
| FMR LLC | 6.2% | ||
| Abigail P. Johnson | 6.2% | ||
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 1 | 16.6% |
12/5/2025
Event 11/30/2025
|
|
|
FMR LLC
13G/A
Amendment 5
|
10.4% |
11/5/2025
Event 9/30/2025
|
|
| FMR LLC | 10.4% | ||
| Abigail P. Johnson | 10.4% | ||
| T. Rowe Price Investment Management, Inc. 13G | 11.3% |
9/8/2025
Event 8/31/2025
|
|
|
New Enterprise Associates 15, L.P.
13D/A
Amendment 4
|
5.5% |
8/14/2025
Event 8/12/2025
|
|
| New Enterprise Associates 15, L.P. | 5.5% | ||
| NEA Partners 15, L.P. | 5.5% | ||
| Nea 15 GP, LLC | 5.5% | ||
| Forest Baskett | 5.5% | ||
| Anthony A. Florence, Jr. | 5.5% | ||
| Mohamad H. Makhzoumi | 5.5% | ||
| Scott D. Sandell | 5.5% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 4
|
4.5% |
8/14/2025
Event 6/30/2025
|
|
| Perceptive Advisors LLC | 4.5% | ||
| Joseph Edelman | 4.5% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 4.5% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 3
|
5.3% |
5/15/2025
Event 3/31/2025
|
|
| Perceptive Advisors LLC | 5.3% | ||
| Joseph Edelman | 5.3% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 5.3% | ||
|
New Enterprise Associates 15, L.P.
13D/A
Amendment 3
|
6.8% |
5/12/2025
Event 5/8/2025
|
|
| New Enterprise Associates 15, L.P. | 6.8% | ||
| NEA Partners 15, L.P. | 6.8% | ||
| Nea 15 GP, LLC | 6.8% | ||
| Forest Baskett | 6.8% | ||
| Anthony A. Florence, Jr. | 6.8% | ||
| Mohamad H. Makhzoumi | 6.8% | ||
| Scott D. Sandell | 6.8% | ||
| Peter W. Sonsini | 0% | ||
|
FMR LLC
13G/A
Amendment 4
|
11.5% |
5/12/2025
Event 3/31/2025
|
|
| FMR LLC | 11.5% | ||
| Abigail P. Johnson | 11.5% | ||
| Vanguard Group Inc 13G/A Amendment 1 | 7.3% |
4/30/2025
Event 3/31/2025
|
|
| BlackRock, Inc. 13G/A Amendment 2 | 6.4% |
4/17/2025
Event 3/31/2025
|
|
| Rami Elghandour 13D/A Amendment 1 | 6.9% |
2/27/2025
Event 2/27/2025
|
|
|
FMR LLC
13G/A
Amendment 3
|
14.7% |
2/12/2025
Event 12/31/2024
|
|
| FMR LLC | 14.7% | ||
| Abigail P. Johnson | 14.7% | ||
| Vanguard Group Inc 13G | 6.2% |
1/30/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 2 | 30.0 k | $3.43 M |
| 2026 Q1 | 267 | 57.0 M | $6.52 B |
| 2025 Q4 | 232 | 72.3 M | $4.71 B |
| 2025 Q3 | 224 | 63.9 M | $5.25 B |
| 2025 Q2 | 218 | 61.4 M | $4.01 B |
| 2025 Q1 | 216 | 61.9 M | $4.06 B |
| 2024 Q4 | 227 | 59.2 M | $4.54 B |
| 2024 Q3 | 207 | 49.7 M | $4.15 B |
| 2024 Q2 | 176 | 51.9 M | $2.86 B |
| 2024 Q1 | 194 | 50.3 M | $3.50 B |
| 2023 Q4 | 171 | 49.6 M | $2.75 B |
| 2023 Q3 | 143 | 48.7 M | $1.75 B |
| 2023 Q2 | 145 | 49.3 M | $1.56 B |
| 2023 Q1 | 126 | 46.7 M | $1.44 B |
| 2022 Q4 | 133 | 44.2 M | $1.37 B |
| 2022 Q3 | 79 | 42.9 M | $805 M |
| 2022 Q2 | 69 | 34.9 M | $622 M |
| 2022 Q1 | 50 | 26.9 M | $358 M |